Drug profile · INN
lactulose
ACILAC
lactulose (ACILAC) is a colonic bacteria substrate. Associated with Teva Pharma GmbH. Route of administration: oral, rectal. Current US regulatory status: approved.
Drug details — lactulose
- US status
- approved
- Class
- —
- Route
- ORAL, RECTAL
- Patents
- 2
- Programs
- 6
- Data quality
- 0.89
Quick answer
lactulose (ACILAC) is a colonic bacteria substrate. Associated with Teva Pharma GmbH. Route of administration: oral, rectal. Current US regulatory status: approved.
Key facts
Mechanism of action
Colonic bacteria substrate
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related patents
Frequently asked questions
What is lactulose?
lactulose (ACILAC) is a colonic bacteria substrate. Associated with Teva Pharma GmbH. Route of administration: oral, rectal. Current US regulatory status: approved.
What is the brand name for lactulose?
ACILAC is a marketed brand name for lactulose. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lactulose?
lactulose has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.